AHCYL2 Antibodies

Santa Cruz Biotechnology features a diverse variety of AHCYL2 monoclonal antibodies for investigating AHCYL2 in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AHCYL2, or S-adenosylhomocysteine hydrolase-like 2, plays a key role in regulating cellular methylation processes and metabolizing S-adenosylhomocysteine. AHCYL2 maintains cellular homeostasis through its involvement in various biological pathways. Research has shown AHCYL2's significance in cancer development and neurodegenerative conditions. Scientists studying AHCYL2 continue to uncover new functions and potential therapeutic applications. Investigating AHCYL2 can reveal important insights about cellular regulation and disease mechanisms. Understanding AHCYL2's role in methylation could lead to novel therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of AHCYL2's biological significance.